Health Watch | These special traits may shield ‘SuperAgers’ from dementia — how they could lead to new Alzheimer’s tools

Title: These special traits may shield ‘SuperAgers’ from dementia — how they could lead to new Alzheimer’s tools

Article Snip: "...Life expectancy in the US hovers around 78.4 years — there’s a special group of people who surpass this mark with flying colors. The retirees, known as “SuperAgers,” exhibit the memory and cognitive abilities of people in middle age.

A new report out of Northwestern University reveals unique traits of SuperAger brains that appear to shield them from dementia. ..."

Reference: nypost.com
Health Watch, SuperAgers, Dementia,Alzheimer's,

---

---

FDA fully approves 'novel' Alzheimer’s disease drug Leqembi, will be covered by Medicare

Title: FDA fully approves 'novel' Alzheimer’s disease drug Leqembi, will be covered by Medicare

Article Snip: "Leqembi has shown clinical benefit in fighting Alzheimer's disease. ...The Food and Drug Administration (FDA) has fully approved a "novel" drug used to treat adult patients with Alzheimer’s, the agency announced. Leqembi, which is produced by Japanese drugmaker Eisai and American-based drugmaker Biogen..."

Reference: www.foxnews.com
Leqembi,Medicare,Alzheimer's, Health,Alzheimer’s Drugs,Food and Drug Administration (FDA),amyloid beta-directed antibody, Biogen, Eisai, Lecanemab,

---

---